Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FAPIBiotin PET/CT in Various Cancers
NCT06734572Phase 1Recruiting
- Sponsor
- The First Hospital of Fujian Medical University
- Start
- Jun 2024
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by The First Hospital of Fujian Medical University. Primary endpoint: Dosimetry of normal organs and tumors at 120 months. Started Jun 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06734572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06734572.